![Frontiers | Functional Metabolomics Analysis Elucidating the Metabolic Biomarker and Key Pathway Change Associated With the Chronic Glomerulonephritis and Revealing Action Mechanism of Rhein Frontiers | Functional Metabolomics Analysis Elucidating the Metabolic Biomarker and Key Pathway Change Associated With the Chronic Glomerulonephritis and Revealing Action Mechanism of Rhein](https://www.frontiersin.org/files/Articles/554783/fphar-11-554783-HTML/image_m/fphar-11-554783-g001.jpg)
Frontiers | Functional Metabolomics Analysis Elucidating the Metabolic Biomarker and Key Pathway Change Associated With the Chronic Glomerulonephritis and Revealing Action Mechanism of Rhein
![Angiotensin II increases glomerular permeability by β-arrestin mediated nephrin endocytosis | Scientific Reports Angiotensin II increases glomerular permeability by β-arrestin mediated nephrin endocytosis | Scientific Reports](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fsrep39513/MediaObjects/41598_2016_Article_BFsrep39513_Fig5_HTML.jpg)
Angiotensin II increases glomerular permeability by β-arrestin mediated nephrin endocytosis | Scientific Reports
![Evidence for Angiotensin-Converting Enzyme– and Chymase-Mediated Angiotensin II Formation in the Interstitial Fluid Space of the Dog Heart In Vivo | Circulation Evidence for Angiotensin-Converting Enzyme– and Chymase-Mediated Angiotensin II Formation in the Interstitial Fluid Space of the Dog Heart In Vivo | Circulation](https://www.ahajournals.org/cms/asset/6c7982ba-23e1-423b-8c28-a4b03e5eb033/hc1992705001.jpg)
Evidence for Angiotensin-Converting Enzyme– and Chymase-Mediated Angiotensin II Formation in the Interstitial Fluid Space of the Dog Heart In Vivo | Circulation
![Angiotensin II increases glomerular permeability by β-arrestin mediated nephrin endocytosis | Scientific Reports Angiotensin II increases glomerular permeability by β-arrestin mediated nephrin endocytosis | Scientific Reports](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fsrep39513/MediaObjects/41598_2016_Article_BFsrep39513_Fig7_HTML.jpg)
Angiotensin II increases glomerular permeability by β-arrestin mediated nephrin endocytosis | Scientific Reports
![Evidence for Angiotensin-Converting Enzyme– and Chymase-Mediated Angiotensin II Formation in the Interstitial Fluid Space of the Dog Heart In Vivo | Circulation Evidence for Angiotensin-Converting Enzyme– and Chymase-Mediated Angiotensin II Formation in the Interstitial Fluid Space of the Dog Heart In Vivo | Circulation](https://www.ahajournals.org/cms/asset/1b78d888-90cc-4715-8d3d-2b17f9a54c34/hc1992705006.jpeg)
Evidence for Angiotensin-Converting Enzyme– and Chymase-Mediated Angiotensin II Formation in the Interstitial Fluid Space of the Dog Heart In Vivo | Circulation
![Frontiers | The Effects of Amphetamine and Methamphetamine on the Release of Norepinephrine, Dopamine and Acetylcholine From the Brainstem Reticular Formation Frontiers | The Effects of Amphetamine and Methamphetamine on the Release of Norepinephrine, Dopamine and Acetylcholine From the Brainstem Reticular Formation](https://www.frontiersin.org/files/Articles/443851/fnana-13-00048-HTML/image_m/fnana-13-00048-g001.jpg)
Frontiers | The Effects of Amphetamine and Methamphetamine on the Release of Norepinephrine, Dopamine and Acetylcholine From the Brainstem Reticular Formation
![Sigma non-opioid receptor 1 is a potential therapeutic target for long QT syndrome | Nature Cardiovascular Research Sigma non-opioid receptor 1 is a potential therapeutic target for long QT syndrome | Nature Cardiovascular Research](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs44161-021-00016-2/MediaObjects/44161_2021_16_Fig1_HTML.png)
Sigma non-opioid receptor 1 is a potential therapeutic target for long QT syndrome | Nature Cardiovascular Research
![Functional and Biochemical Analysis of Angiotensin II–Forming Pathways in the Human Heart | Circulation Research Functional and Biochemical Analysis of Angiotensin II–Forming Pathways in the Human Heart | Circulation Research](https://www.ahajournals.org/cms/asset/fa76685e-565f-48f0-8e54-3efde354b42b/0863f3.jpg)
Functional and Biochemical Analysis of Angiotensin II–Forming Pathways in the Human Heart | Circulation Research
![Effects of chymostatin, a chymase inhibitor, on blood pressure, plasma and tissue angiotensin II, renal haemodynamics and renal excretion in two models of hypertension in the rat - Roszkowska‐Chojecka - 2015 - Effects of chymostatin, a chymase inhibitor, on blood pressure, plasma and tissue angiotensin II, renal haemodynamics and renal excretion in two models of hypertension in the rat - Roszkowska‐Chojecka - 2015 -](https://physoc.onlinelibrary.wiley.com/cms/asset/331bdbe6-c031-486d-8ce5-10010f9996be/eph1647-fig-0003-m.jpg)
Effects of chymostatin, a chymase inhibitor, on blood pressure, plasma and tissue angiotensin II, renal haemodynamics and renal excretion in two models of hypertension in the rat - Roszkowska‐Chojecka - 2015 -
![Functional and Biochemical Analysis of Angiotensin II–Forming Pathways in the Human Heart | Circulation Research Functional and Biochemical Analysis of Angiotensin II–Forming Pathways in the Human Heart | Circulation Research](https://www.ahajournals.org/cms/asset/63272d22-9e86-4090-b768-ba542f931486/0863f1.jpg)
Functional and Biochemical Analysis of Angiotensin II–Forming Pathways in the Human Heart | Circulation Research
![Functional and Biochemical Analysis of Angiotensin II–Forming Pathways in the Human Heart | Circulation Research Functional and Biochemical Analysis of Angiotensin II–Forming Pathways in the Human Heart | Circulation Research](https://www.ahajournals.org/cms/asset/ea6a03a4-9dc9-42bf-a3fc-9f1dd29211be/0863f2.jpg)
Functional and Biochemical Analysis of Angiotensin II–Forming Pathways in the Human Heart | Circulation Research
![Angiotensin II increases glomerular permeability by β-arrestin mediated nephrin endocytosis | Scientific Reports Angiotensin II increases glomerular permeability by β-arrestin mediated nephrin endocytosis | Scientific Reports](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fsrep39513/MediaObjects/41598_2016_Article_BFsrep39513_Fig6_HTML.jpg)
Angiotensin II increases glomerular permeability by β-arrestin mediated nephrin endocytosis | Scientific Reports
![Angiotensin II increases glomerular permeability by β-arrestin mediated nephrin endocytosis | Scientific Reports Angiotensin II increases glomerular permeability by β-arrestin mediated nephrin endocytosis | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fsrep39513/MediaObjects/41598_2016_Article_BFsrep39513_Fig1_HTML.jpg)
Angiotensin II increases glomerular permeability by β-arrestin mediated nephrin endocytosis | Scientific Reports
![Associations of ACE I/D polymorphism with the levels of ACE, kallikrein, angiotensin II and interleukin-6 in STEMI patients | Scientific Reports Associations of ACE I/D polymorphism with the levels of ACE, kallikrein, angiotensin II and interleukin-6 in STEMI patients | Scientific Reports](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-019-56263-8/MediaObjects/41598_2019_56263_Fig1_HTML.png)
Associations of ACE I/D polymorphism with the levels of ACE, kallikrein, angiotensin II and interleukin-6 in STEMI patients | Scientific Reports
![Angiotensin II increases glomerular permeability by β-arrestin mediated nephrin endocytosis | Scientific Reports Angiotensin II increases glomerular permeability by β-arrestin mediated nephrin endocytosis | Scientific Reports](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fsrep39513/MediaObjects/41598_2016_Article_BFsrep39513_Fig2_HTML.jpg)